Patents by Inventor Douglas C. Hovey

Douglas C. Hovey has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Nanoparticulate compositions of mitogen-activated protein (MAP) kinase inhibitors
    Patent number: 7998507
    Abstract: Nanoparticulate compositions comprising at least one poorly soluble MAP kinase inhibitor and at least one surface stabilizer are described. The nanoparticulate compositions have an average particle size of less than about 2000 nm. The invention also describes methods of making and using such compositions.
    Type: Grant
    Filed: December 7, 2005
    Date of Patent: August 16, 2011
    Assignee: Elan Pharma International Ltd.
    Inventors: H. William Bosch, Greta G. Cary, Douglas C. Hovey, Rajeev A. Jain, Laura J. Kline, Elaine Merisko-Liversidge, Kevin D. Ostrander, Niels P. Ryde, Stephen B. Ruddy
  • LIQUID DOSAGE COMPOSITIONS OF STABLE NANOPARTICULATE ACTIVE AGENTS
    Publication number: 20110165251
    Abstract: The present invention relates to liquid dosage compositions of stable nanoparticulate active agents. The liquid dosage compositions of the invention include osmotically active crystal growth inhibitors that stabilize the nanoparticulate active agents against crystal and particle size growth of the active agent.
    Type: Application
    Filed: March 9, 2011
    Publication date: July 7, 2011
    Inventors: H. William BOSCH, Matthew R. HILBORN, Douglas C. HOVEY, Laura J. KLINE, Robert W. LEE, John D. PRUITT, Niels P. RYDE, Tuula A. RYDE, Shuqian XU
  • Liquid dosage compositions of stable nanoparticulate active agents
    Publication number: 20040258757
    Abstract: The present invention relates to liquid dosage compositions of stable nanoparticulate active agents. The liquid dosage compositions of the invention include osmotically active crystal growth inhibitors that stabilize the nanoparticulate active agents against crystal and particle size growth of the active agent.
    Type: Application
    Filed: July 16, 2003
    Publication date: December 23, 2004
    Applicant: Elan Pharma International, Ltd.
    Inventors: H. William Bosch, Matthew R. Hilborn, Douglas C. Hovey, Laura J. Kline, Robert W. Lee, John D. Pruitt, Niels P. Ryde, Tuula A. Ryde, Shuqian Xu
  • Solid dosage forms comprising pullulan
    Publication number: 20040156895
    Abstract: Disclosed are solid dosage forms of active agents and pullulan. The solid dosage form has a friability of less than about 1%.
    Type: Application
    Filed: November 12, 2003
    Publication date: August 12, 2004
    Applicant: Elan Pharma International Ltd.
    Inventors: John D. Pruitt, Douglas C. Hovey, Tuula A. Ryde, H. William Bosch, Robert W. Lee
  • Nanoparticulate compositions comprising amorphous cyclosporine and methods of making and using such compositions
    Patent number: 6656504
    Abstract: Nanoparticulate amorphous cyclosporine formulations, and nanoparticulate cyclosporine formulations comprising a mixture of amorphous and crystalline cyclosporine, having effective average particle sizes of less than about 2000 nm are described. The compositions exhibit increased bioavailability and increased consistency of bioavailability as compared to prior macro-sized cyclosporine and formulations. Methods of making and using the compositions are also described.
    Type: Grant
    Filed: September 9, 1999
    Date of Patent: December 2, 2003
    Assignee: Elan Pharma International Ltd.
    Inventors: H. William Bosch, Kevin D. Ostrander, Douglas C. Hovey
  • Nanoparticulate compositions of mitogen-activated protein (MAP) kinase inhibitors
    Publication number: 20030181411
    Abstract: Nanoparticulate compositions comprising at least one poorly soluble MAP kinase inhibitor and at least one surface stabilizer are described. The nanoparticulate compositions have an average particle size of less than about 2000 nm. The invention also describes methods of making and using such compositions.
    Type: Application
    Filed: March 20, 2003
    Publication date: September 25, 2003
    Applicant: Elan Pharma International Ltd.
    Inventors: H. William Bosch, Greta G. Cary, Douglas C. Hovey, Rajeev A. Jain, Laura J. Kline, Elaine Merisko-Liversidge, Kevin D. Ostrander